-
2
-
-
84860600115
-
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
-
Staud R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother 2012;12:577-585.
-
(2012)
Expert Rev Neurother
, vol.12
, pp. 577-585
-
-
Staud, R.1
-
3
-
-
63449092750
-
Descending control of nociception: Specificity, recruitment and plasticity
-
Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev. 2009;60:214-225.
-
(2009)
Brain Res Rev.
, vol.60
, pp. 214-225
-
-
Heinricher, M.M.1
Tavares, I.2
Leith, J.L.3
Lumb, B.M.4
-
4
-
-
84868542805
-
Basic opioid pharmacology: An update
-
Pathan H, Williams J. Basic opioid pharmacology: An update. Br J Pain 2012;6:11-16.
-
(2012)
Br J Pain
, vol.6
, pp. 11-16
-
-
Pathan, H.1
Williams, J.2
-
5
-
-
33750630238
-
Noradrenergic pain modulation
-
Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006;80:53-83.
-
(2006)
Prog Neurobiol
, vol.80
, pp. 53-83
-
-
Pertovaara, A.1
-
6
-
-
77951623401
-
Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes
-
van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain 2010;11:408-419.
-
(2010)
J Pain
, vol.11
, pp. 408-419
-
-
van Wijk, G.1
Veldhuijzen, D.S.2
-
7
-
-
0013851199
-
Pain mechanisms: A new theory
-
Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965;150:971-979.
-
(1965)
Science
, vol.150
, pp. 971-979
-
-
Melzack, R.1
Wall, P.D.2
-
8
-
-
79960149270
-
Biomarkers for chronic pain and analgesia. Part 1: The need, reality, challenges, and solutions
-
Borsook D, Becerra L, Hargreaves R. Biomarkers for chronic pain and analgesia. Part 1: The need, reality, challenges, and solutions. Discov Med 2011;11:197-207.
-
(2011)
Discov Med
, vol.11
, pp. 197-207
-
-
Borsook, D.1
Becerra, L.2
Hargreaves, R.3
-
9
-
-
1842452956
-
Biomarkers for pain
-
Kalso E. Biomarkers for pain. Pain 2004;107:199-201.
-
(2004)
Pain
, vol.107
, pp. 199-201
-
-
Kalso, E.1
-
10
-
-
65949117820
-
Pain biomarkers
-
Marchi A, Vellucci R, Mameli S, Rita Piredda A, Finco G. Pain biomarkers. Clin Drug Investig 2009;29(suppl 1):41-46.
-
(2009)
Clin Drug Investig
, vol.29
, Issue.SUPPL 1
, pp. 41-46
-
-
Marchi, A.1
Vellucci, R.2
Mameli, S.3
Rita Piredda, A.4
Finco, G.5
-
11
-
-
41149090715
-
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
-
Roche S, Gabelle A, Lehmann S. Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers. Proteomics Clin Appl 2008;2:428-436.
-
(2008)
Proteomics Clin Appl
, vol.2
, pp. 428-436
-
-
Roche, S.1
Gabelle, A.2
Lehmann, S.3
-
12
-
-
84862242457
-
[Pain and consciousness mocks philosophers and scientists]
-
Bäckryd E. [Pain and consciousness mocks philosophers and scientists]. Lakartidningen 2012;109:1039-1040.
-
(2012)
Lakartidningen
, vol.109
, pp. 1039-1040
-
-
Bäckryd, E.1
-
13
-
-
1542268262
-
Pain: Moving from symptom control toward mechanism-specific pharmacologic management
-
Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-451.
-
(2004)
Ann Intern Med
, vol.140
, pp. 441-451
-
-
Woolf, C.J.1
-
14
-
-
0024253671
-
Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome)
-
Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988;15:1804-1806.
-
(1988)
J Rheumatol
, vol.15
, pp. 1804-1806
-
-
Vaeroy, H.1
Helle, R.2
Forre, O.3
Kass, E.4
Terenius, L.5
-
15
-
-
84866165807
-
Volume transmission of beta-endorphin via the cerebrospinal fluid; a review
-
Veening JG, Gerrits PO, Barendregt HP. Volume transmission of beta-endorphin via the cerebrospinal fluid; a review. Fluids Barriers CNS 2012;9:16.
-
(2012)
Fluids Barriers CNS
, vol.9
, pp. 16
-
-
Veening, J.G.1
Gerrits, P.O.2
Barendregt, H.P.3
-
16
-
-
0038714965
-
Neuropeptides: Opportunities for drug discovery
-
Hokfelt T, Bartfai T, Bloom F. Neuropeptides: Opportunities for drug discovery. Lancet Neurol 2003;2:463-472.
-
(2003)
Lancet Neurol
, vol.2
, pp. 463-472
-
-
Hokfelt, T.1
Bartfai, T.2
Bloom, F.3
-
18
-
-
0037109674
-
Spinal neurons that possess the substance P receptor are required for the development of central sensitization
-
Khasabov SG, Rogers SD, Ghilardi JR, etal. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 2002;22:9086-9098.
-
(2002)
J Neurosci
, vol.22
, pp. 9086-9098
-
-
Khasabov, S.G.1
Rogers, S.D.2
Ghilardi, J.R.3
-
19
-
-
0028104819
-
Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
-
Russell IJ, Orr MD, Littman B, etal. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-1601.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 1593-1601
-
-
Russell, I.J.1
Orr, M.D.2
Littman, B.3
-
20
-
-
0023919037
-
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis
-
Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988;32:21-26.
-
(1988)
Pain
, vol.32
, pp. 21-26
-
-
Vaeroy, H.1
Helle, R.2
Forre, O.3
Kass, E.4
Terenius, L.5
-
21
-
-
84861222902
-
Between Metabolite Relationships: An essential aspect of metabolic change
-
Jansen JJ, Szymanska E, Hoefsloot HC, etal. Between Metabolite Relationships: An essential aspect of metabolic change. Metabolomics 2012;8:422-432.
-
(2012)
Metabolomics
, vol.8
, pp. 422-432
-
-
Jansen, J.J.1
Szymanska, E.2
Hoefsloot, H.C.3
-
22
-
-
34347250900
-
A multivariate screening strategy for investigating metabolic effects of strenuous physical exercise in human serum
-
Pohjanen E, Thysell E, Jonsson P, etal. A multivariate screening strategy for investigating metabolic effects of strenuous physical exercise in human serum. J Proteome Res 2007;6:2113-2120.
-
(2007)
J Proteome Res
, vol.6
, pp. 2113-2120
-
-
Pohjanen, E.1
Thysell, E.2
Jonsson, P.3
-
24
-
-
0018103950
-
Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes
-
Almay BG, Johansson F, Von Knorring L, Terenius L, Wahlstrom A. Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain 1978;5:153-162.
-
(1978)
Pain
, vol.5
, pp. 153-162
-
-
Almay, B.G.1
Johansson, F.2
Von Knorring, L.3
Terenius, L.4
Wahlstrom, A.5
-
25
-
-
84940141191
-
Investigation on cerebrospinal fluid opioids and neurotransmitters related to spinal cord stimulation
-
Tonelli L, Setti T, Falasca A, etal. Investigation on cerebrospinal fluid opioids and neurotransmitters related to spinal cord stimulation. Appl Neurophysiol 1988;51:324-332.
-
(1988)
Appl Neurophysiol
, vol.51
, pp. 324-332
-
-
Tonelli, L.1
Setti, T.2
Falasca, A.3
-
26
-
-
0026770981
-
Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines
-
Fujiwara N, Shimoji K, Kumagai Y, Endoh H, Fukuda S. Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines. Acta Neurochir (Wien) 1992;117:38-43.
-
(1992)
Acta Neurochir (Wien)
, vol.117
, pp. 38-43
-
-
Fujiwara, N.1
Shimoji, K.2
Kumagai, Y.3
Endoh, H.4
Fukuda, S.5
-
27
-
-
0021048826
-
Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life
-
Facchinetti F, Nappi G, Martignoni E, etal. Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life. Peptides 1983;4:469-474.
-
(1983)
Peptides
, vol.4
, pp. 469-474
-
-
Facchinetti, F.1
Nappi, G.2
Martignoni, E.3
-
28
-
-
0026871251
-
Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid
-
Bach FW, Schmidt JF, Faber T. Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid. Clin Chem 1992;38:847-852.
-
(1992)
Clin Chem
, vol.38
, pp. 847-852
-
-
Bach, F.W.1
Schmidt, J.F.2
Faber, T.3
-
29
-
-
0031952573
-
Age-related changes in the cerebrospinal fluid level of beta-endorphin and substance P. Short communication
-
Nagamitsu S, Matsuishi T, Komori H, etal. Age-related changes in the cerebrospinal fluid level of beta-endorphin and substance P. Short communication. J Neural Transm 1998;105:53-58.
-
(1998)
J Neural Transm
, vol.105
, pp. 53-58
-
-
Nagamitsu, S.1
Matsuishi, T.2
Komori, H.3
-
30
-
-
0023261865
-
Beta endorphin levels in CSF during methadone maintenance
-
Kosten TR, Kreek MJ, Swift C, Carney MK, Ferdinands L. Beta endorphin levels in CSF during methadone maintenance. Life Sci 1987;41:1071-1076.
-
(1987)
Life Sci
, vol.41
, pp. 1071-1076
-
-
Kosten, T.R.1
Kreek, M.J.2
Swift, C.3
Carney, M.K.4
Ferdinands, L.5
-
31
-
-
84874969868
-
What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?
-
Bruehl S, Burns JW, Chung OY, Chont M. What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function? Eur J Pain 2012;16:370-380.
-
(2012)
Eur J Pain
, vol.16
, pp. 370-380
-
-
Bruehl, S.1
Burns, J.W.2
Chung, O.Y.3
Chont, M.4
-
32
-
-
0023892329
-
Substance P in CSF of patients with chronic pain syndromes
-
Almay BG, Johansson F, Von Knorring L, Le Greves P, Terenius L. Substance P in CSF of patients with chronic pain syndromes. Pain 1988;33:3-9.
-
(1988)
Pain
, vol.33
, pp. 3-9
-
-
Almay, B.G.1
Johansson, F.2
Von Knorring, L.3
Le Greves, P.4
Terenius, L.5
-
33
-
-
0031450220
-
Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc
-
Lindh C, Liu Z, Lyrenas S, Ordeberg G, Nyberg F. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997;26:468-472.
-
(1997)
Scand J Rheumatol
, vol.26
, pp. 468-472
-
-
Lindh, C.1
Liu, Z.2
Lyrenas, S.3
Ordeberg, G.4
Nyberg, F.5
-
34
-
-
0029843327
-
[Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]
-
Strittmatter M, Grauer M, Isenberg E, etal. [Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]. Schmerz 1996;10:261-268.
-
(1996)
Schmerz
, vol.10
, pp. 261-268
-
-
Strittmatter, M.1
Grauer, M.2
Isenberg, E.3
-
35
-
-
0031772214
-
Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome
-
Evengard B, Nilsson CG, Lindh G, etal. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998;78:153-155.
-
(1998)
Pain
, vol.78
, pp. 153-155
-
-
Evengard, B.1
Nilsson, C.G.2
Lindh, G.3
-
36
-
-
84877644805
-
A potential role for substance P and interleukin-6 in the cerebrospinal fluid of Cavalier King Charles Spaniels with neuropathic pain
-
Schmidt MJ, Roth J, Ondreka N, Kramer M, Rummel C. A potential role for substance P and interleukin-6 in the cerebrospinal fluid of Cavalier King Charles Spaniels with neuropathic pain. J Vet Intern Med 2013;27:530-535.
-
(2013)
J Vet Intern Med
, vol.27
, pp. 530-535
-
-
Schmidt, M.J.1
Roth, J.2
Ondreka, N.3
Kramer, M.4
Rummel, C.5
-
37
-
-
77954877647
-
The role of glia and the immune system in the development and maintenance of neuropathic pain
-
Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010;10:167-184.
-
(2010)
Pain Pract
, vol.10
, pp. 167-184
-
-
Vallejo, R.1
Tilley, D.M.2
Vogel, L.3
Benyamin, R.4
-
38
-
-
84882559726
-
Mechanisms of glial activation after nerve injury
-
Basbaum AI, Bushnell C, eds. Oxford, UK & San Diego, CA: Elsevier
-
Watkins LR, Milligan ED, Maier SF. Mechanisms of glial activation after nerve injury. In: Basbaum AI, Bushnell C, eds. Science of Pain. Oxford, UK & San Diego, CA: Elsevier; 2009:429-433.
-
(2009)
Science of Pain
, pp. 429-433
-
-
Watkins, L.R.1
Milligan, E.D.2
Maier, S.F.3
|